Pathogenicity of Helicobacter rodentium in A/JCr and SCID mice

Matthew H Myles1, Robert S Livingston, Craig L Franklin

  • 1Research Animal Diagnostic Laboratory, Department of Veterinary Pathobiology, University of Missouri, Columbia, Missouri, USA.

Comparative Medicine
|December 4, 2004
PubMed

Insights

Helicobacter rodentium does not cause disease alone but can worsen enteritis when co-infecting mice with Helicobacter hepaticus. This study investigated H. rodentium's pathogenicity and its role in augmenting disease during co-infection.

Area of Science:

  • Microbiology
  • Immunology
  • Gastroenterology

Background:

  • Helicobacter rodentium was initially identified as a potential pathogen in immunocompromised mice exhibiting diarrhea.
  • Co-infection with H. rodentium and H. bilis resulted in more severe disease than H. bilis alone, suggesting H. rodentium's contribution to enteritis pathogenesis.

Purpose of the Study:

  • To determine if Helicobacter rodentium is pathogenic in mice.
  • To investigate whether H. rodentium augments disease severity during co-infection with a pathogenic Helicobacter species.

Main Methods:

  • Mice (A/JCr and C.B-17/IcrCrl-scidBr) were inoculated with H. rodentium and/or H. hepaticus.
  • Cecal and liver tissues were microscopically examined for disease.
  • Cecal mRNA levels of immune-related genes (IP-10, MIP-1alpha, IL-10, IFN-gamma) were quantified.

Main Results:

  • H. rodentium mono-infection did not cause significant hepatic or cecal lesions or alter immune gene expression compared to controls.
  • H. hepaticus infection led to moderate to severe hepatitis, increased cecal lesions, and elevated immune gene expression.
  • Co-infection with H. hepaticus and H. rodentium in immunodeficient mice exacerbated clinical signs (liquid cecal contents, low body weight) and significantly increased cecal immune gene expression.

Conclusions:

  • Helicobacter rodentium is not pathogenic on its own in the studied mouse models.
  • Co-infection with H. hepaticus and H. rodentium significantly augments disease severity and mucosal immune responses in immunodeficient mice.

Related Concept Videos